Sign in
CompletedPhase 1

A clinical trial of MK-3868 in healthy participants (MK-3868-001)

Key facts

Who runs it
Merck Sharp & Dohme LLC
Where
Belgium1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1
People taking part
16 people enrolled
Started
31 Jul 2026
Ended
30 Oct 2026
Type of study
Interventional
Record updated
27 July 2026

Who can take part

Age
18 years to 64 years
Sex
Men only
Healthy volunteers
Can take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
27 July 2026